Skip to content

Training Dual-Task Walking After Stroke

Training Dual-Task Walking After Stroke: Effects on Attentional and Locomotor Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01568957
Enrollment
37
Registered
2012-04-02
Start date
2011-09-30
Completion date
2017-11-15
Last updated
2017-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Gait, Dual-task, Obstacle avoidance, Attention allocation

Brief summary

Community ambulation is a highly complex skill requiring the ability to adapt to increased environmental complexity and perform multiple tasks simultaneously. Deficits in dual-tasking may severely compromise the ability to participate fully in community living. Unfortunately, current rehabilitation practice for stroke fails to adequately address dual-task limitations; individuals with stroke continue to exhibit clinically significant dual-task costs on gait at discharge. As a result, many stroke survivors are living in the community with residual deficits that may increase disability in the real world and lead to falls with devastating consequences. To address this issue, the proposed study investigates the efficacy of dual-task gait training on attention allocation and locomotor performance in community-dwelling stroke survivors. Because walking in the real world often requires time-critical tasks and obstacle avoidance, the investigators will test the impact of dual-task gait training on cognitive-motor interference during walking at preferred speed and at maximal speed (Aim 1), and on locomotor control during obstacle negotiation (Aim 2). The investigators will also evaluate the effects of the intervention on community reintegration and participation (Aim 3).

Interventions

BEHAVIORALGait training

Twelve 30-minute sessions plus 10-minute stretching and warm up, provided 3 times per weeks for 4 weeks. Up to 6 weeks are allowed to complete the 12 sessions.

Sponsors

University of Arizona
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Within 3 years of stroke onset * Living in the community, operationally defined as living in one's own home, or the home of a friend, relative, or caregiver * Walking speed 0.6-1.1 m/s determined during 10-meter walk test * Walk without the assistance of another person * Medically stable and approved for participation by study physician * Intact global cognition indicated by score \> 23 on Montreal Cognitive Assessment * Living in the community prior to stroke

Exclusion criteria

* Pre-existing neurological disorders (e.g., Parkinson's disease, Multiple Sclerosis, dementia, traumatic brain injury) * Previous stroke with residual motor deficit * Uncontrolled hypertension * Inability to follow 3-step command * Primary uncontrolled hearing impairment * Severe uncontrolled visual impairment * Any speech-language impairment affecting ability to respond verbally to auditory stimuli * Timed Up and Go test \> 15 seconds * Lower extremity amputation * Any orthopedic problem affecting gait * Concurrent participation in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Dual-task cost on gait speed4 weeksThe dual-task cost represents the difference between single and dual-task walking speed.

Secondary

MeasureTime frameDescription
Executive functionMeasured at baseline, post intervention (4 weeks), 6 months post interventionA computerized version of the Stroop task will be used to assess changes in executive function.
Spontaneous physical activityMeasured at baseline, post intervention (4 weeks), 6 months post interventionSpontaneous physical activity will be assessed with an activity monitor (PAMSys) worn for two consecutive days at each assessment timepoint.
Kinematics of gait during obstacle crossingMeasured at baseline, post intervention (4 weeks), 6 months post intervention
Stroke Impact ScaleMeasured at baseline, post intervention (4 weeks), 6 months post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026